Table 1 Demographic data of 13 patients with previous encephalitis caused by reactivated varicella-zoster virus.

From: Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study

Gender/age at follow-up

Education (years)

Viral load at acute disease (copies/ml)

MRI/CT at acute disease

Iv treat-ment (days)

Follow-up (mo. after symptom onset)

LP/cognitive testing at follow-up

F/82

7

100

MRI ND/CT neg

4

85

ND/Yes

F/63

4,5

1,600,000

MRI and CT neg

7

53

Yes/Yesc

M/28

12

25,000

MRI and CT neg

8

42

Yes/Yes

F/24

12

400

MRI ND/CT neg

14

41

Yes/Yes

M/85

7

6,300

Wide-spread white matter changes and general atrophy

a

18

Yes/Yes

M/76

7

7,100

Wide-spread white matter changes periventricularly and subcortically and spot-like changes in the basal ganglia

7

91

Yes/Yes

M/52

11

20,000

Left-sided thalamic and occipital ischemic changes

13

91

Yes/Yes

F/34

13

25 million

ND

12

39

Yes/Yes

M/74

10

500,000

ND

6

33

Yes/Yes

F/35

16

12,600

MRI ND/CT neg

10

36

Yes/Yes

M/32

15

31,600

MRI and CT neg

10

50

Yes/Yes

M/58

5

NDb

MRI and CT neg

14

20

Yes/Yesc

M/73

ND

316,000

MRI neg/CT ND

11

19

Yes/ND

  1. CT computer tomography, Iv intravenous, ND not done, LP lumbar puncture, MRI magnetic resonance imaging.
  2. aOral treatment with valacyklovir 1 g × 3, 7 days.
  3. bOnly qualitative PCR analysis was performed.
  4. cLimited Swedish language.